Xenon Pharmaceuticals Inc.
XENE
Revenue
16.00k
▼-248.00k▼-93.94%
3 Months ChangeAssets
884.01M
▼-35.01M▼-3.81%
3 Months ChangeLiabilities
39.96M
▲8.64M▲27.58%
3 Months ChangeFree Cash Flow
-43.37M
▼-6.75M▼-18.43%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-08
Form 10-Q
ID: 0000950170-24-094109
2024-08-08
Form 8-K
ID: 0000950170-24-093933
2024-06-05
Form 8-K
ID: 0000950170-24-069318
2024-05-09
Form 10-Q
ID: 0000950170-24-057139
2024-05-09
Form 8-K
ID: 0000950170-24-056940
2024-04-19
Form 8-K
ID: 0000950170-24-046023
2024-03-08
Form 8-K
ID: 0000950170-24-028784
2024-02-29
Form 8-K
ID: 0000950170-24-023080
2023-11-30
Form 8-K
ID: 0000950170-23-067040
2023-11-27
Form 8-K
ID: 0000950170-23-066032